Neurobotics

Neurobotics operates across neuroscience research equipment, neurotechnology, medical robotics, and educational products. Its listed offerings span stationary and wearable EEG systems, biosignal-analysis software, NeuroPlay neuroheadsets, eye-tracking and cognitive-testing tools, neurorehabilitation systems, and anthropomorphic robots. This creates a broader product mix than a company focused only on EEG hardware or only on robotics, with potential relevance to research laboratories, rehabilitation settings, and education. The website describes EEG configurations from 8 to 256 channels and includes human and animal physiology research equipment, giving the portfolio a concrete research-instrumentation dimension. Neurobotics’ defensible distinction in the available profile is its combination of research tools, neurorehabilitation technologies, neurofeedback products, and human-like robots under one company, rather than a verified leadership position in any single category.

Neurobotics was founded in February 2004 and is listed as an active private company with an employee-size band of 11–50. Its product range spans EEG systems and analysis software, neuroheadsets, cognitive and behavioral testing, rehabilitation technologies, animal physiology tools, and anthropomorphic robots. As a result, financing-led expansion or a recent acceleration in staffing cannot be substantiated. The clearest inflection point in the profile is the company’s sustained presence since 2004 combined with a diversified product portfolio; the timing and commercial impact of individual product additions are unknown. Without revenue, customer, or deployment figures, it is not possible to determine whether the business is scaling rapidly, maintaining a specialist operation, or shifting emphasis among its product lines. Its trajectory is best characterized as established but difficult to quantify from available public information.